Raine-Bennett Tina, Merchant Maqdooda, Sinclair Fiona, Lee Justine W, Goler Nancy
Division of Research and Regional Women's Health, Kaiser Permanente Northern California, Oakland, and the Department of Obstetrics and Gynecology, the Permanente Medical Group, Oakland and Vallejo, California.
Obstet Gynecol. 2015 Apr;125(4):904-911. doi: 10.1097/AOG.0000000000000742.
To assess the level of risk for adolescents and women who seek emergency contraception through various clinical routes and the opportunities for improved care provision.
This study looked at a retrospective cohort to assess contraception and other reproductive health outcomes among adolescents and women aged 15-44 years who accessed oral levonorgestrel emergency contraception through an office visit or the call center at Kaiser Permanente Northern California from 2010 to 2011.
Of 21,421 prescriptions, 14,531 (67.8%) were accessed through the call center. In the subsequent 12 months, 12,127 (56.6%) adolescents and women had short-acting contraception (pills, patches, rings, depot medroxyprogesterone) dispensed and 2,264 (10.6%) initiated very effective contraception (intrauterine contraception, implants, sterilization). Initiation of very effective contraception was similar for adolescents and women who accessed it through the call center-1,569 (10.8%) and office visits-695 (10.1%) (adjusted odds ratio [OR] 1.02, 95% confidence interval [CI] 0.93-1.13). In the subsequent 6 months, 2,056 (9.6%) adolescents and women became pregnant. Adolescents and women who accessed emergency contraception through the call center were less likely to become pregnant within 3 months of accessing emergency contraception than woman who accessed it through office visits (adjusted OR 0.82, 95% CI 0.72-0.94); however, they were more likely to become pregnant within 4-6 months (adjusted OR 1.37, 95% CI 1.16-1.60). Among adolescents and women who were tested for chlamydia and gonorrhea, 689 (7.8%) and 928 (7.9%) were positive in the 12 months before and after accessing emergency contraception, respectively.
Protocols to routinely address unmet needs for contraception at every call for emergency contraception and all office visits, including visits with primary care providers, should be investigated.
评估通过各种临床途径寻求紧急避孕的青少年和女性的风险水平,以及改善护理服务的机会。
本研究采用回顾性队列研究,以评估2010年至2011年期间,在北加利福尼亚州凯撒医疗集团通过门诊或呼叫中心获取口服左炔诺孕酮紧急避孕药的15至44岁青少年和女性的避孕及其他生殖健康结局。
在21421份处方中,14531份(67.8%)是通过呼叫中心获取的。在随后的12个月里,12127名(56.6%)青少年和女性获得了短效避孕药(药丸、贴片、阴道环、醋酸甲羟孕酮长效避孕针),2264名(10.6%)开始采用高效避孕方法(宫内节育器、皮下埋植剂、绝育)。通过呼叫中心获取高效避孕方法的青少年和女性(1569名,10.8%)与通过门诊获取的(695名,10.1%)相似(校正比值比[OR]为1.02,95%置信区间[CI]为0.93 - 1.13)。在随后的6个月里,2056名(9.6%)青少年和女性怀孕。通过呼叫中心获取紧急避孕药的青少年和女性在获取紧急避孕药后3个月内怀孕的可能性低于通过门诊获取的女性(校正OR为0.82,95%CI为0.72 - 0.94);然而,她们在4至6个月内怀孕的可能性更高(校正OR为1.37,95%CI为1.16 - 1.60)。在接受衣原体和淋病检测的青少年和女性中,在获取紧急避孕药前12个月和后12个月,分别有689名(7.8%)和928名(7.9%)检测呈阳性。
应研究相关方案,以便在每次紧急避孕咨询以及所有门诊就诊(包括与初级保健提供者的就诊)时,常规解决未满足的避孕需求。